Status:
RECRUITING
Improving Clinical Efficiency by Reducing Scheduled Follow-ups Using Cochlear America's Population Mean Mapping Strategy
Lead Sponsor:
Massachusetts Eye and Ear Infirmary
Collaborating Sponsors:
Cochlear
Conditions:
Deafness
Cochlear Hearing Loss
Eligibility:
All Genders
18-85 years
Phase:
NA
Brief Summary
The study is about the importance of each follow-up visit after activating a new cochlear implant in addition to evaluating the effectiveness and efficiency of a new programming strategy from Cochlear...
Eligibility Criteria
Inclusion
- Postlingually deafened
- Adults (18+)
- New cochlear implant recipients with Cochlear Americas devices; identified prior to activation
- Able to perform follow-up testing tasks (repeating words/sentences, indicating they heard a sound stimulus, completing questionnaires)
- English speakers
Exclusion
- Patients who select other cochlear implant manufactured devices
- Pre-lingually deafened
- Multiple disabilities
- Unable to perform follow-up testing tasks (repeating words/sentences, indicating they heard a sound stimulus, completing questionnaires)
- Non-English speakers
- Children under the age of 18
Key Trial Info
Start Date :
February 27 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
February 26 2026
Estimated Enrollment :
48 Patients enrolled
Trial Details
Trial ID
NCT06960616
Start Date
February 27 2024
End Date
February 26 2026
Last Update
May 9 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Mass Eye and Ear
Boston, Massachusetts, United States, 02114